Leadership in Advocacy Development (LEAD) Program
New for 2023, the American Headache Society announces the Leadership in Advocacy Development (LEAD) Program, which aims to provide training, tools, mentorship, and support for mid-career healthcare professionals and physician advocacy leaders in headache medicine.
Participants will explore new opportunities for professional development through formal didactic sessions and small group workshops with leaders in the field on topics including practice management, advocacy, and project management, as well as the development of an advocacy project over a 2-year longitudinal timeframe.
HEALTH AND SAFETY POLICY
The AHS actively monitors the health and safety guidance from the Centers for Disease Control as well as state and local health departments. We want attendees to enjoy a safe environment at all AHS meetings. While the AHS continues to recommend people are up to date on COVID-19 vaccination, attendees of AHS meetings are not required to be vaccinated or verify vaccination status. In addition, masks are optional for AHS meetings and prior antigen testing is not required. We will continue to follow best practices recommended by the Centers for Disease Control and Prevention and abide by any legal mandates and recommendations from government officials in the location of any AHS meeting. These protocols and information are subject to change.
Please note, even with safeguards and the AHS’s overarching commitment to attendee wellness, there remains a risk of contracting COVID-19.
Program Committee
Amaal Starling, MD, MS, FAHS |
| Jessica Ailani, MD, FAHS MedStar Georgetown University Hospital Washington, District of Columbia |
Maureen A. Moriarty, APRN, DNP, FAH Moriarty Associates Westminster, Maryland |
| Olivia Begasse de Dhaem, MD, FAHS Hartford Healthcare Westport, Connecticut |
Barbara Nye Wake Forest Baptist Health Center Winston Salem, North Carolina |
| Larry Charleston IV, MD, MS, FAHS Michigan State University College of Human Medicine East Lansing, Michigan |
Matthew S. Robbins, MD, FAHS Weill Cornell Medicine New York, New York |
| Christopher H. Gottschalk, MD, FAHS Yale Neurology Group New Haven, Connecticut |
Robert E. Shapiro University of Vermont Burlington, Vermont |
| Teshamae Monteith, MD, FAHS University of Miami School of Medicine Miami, Florida |
Leadership in Advocacy Development (LEAD) Program
Leadership in Advocacy Development (LEAD) Program during the 2023 Scottsdale Headache Symposium®
Wednesday, November 15, 2023
JW Marriott Camelback Inn, Scottsdale, AZ
| 8:00 am – 9:00 am | Welcome, Introductions and Organizational Overview
A. Laine Green, MD, MSc, FRCPC, FAHS and R. Allan Purdy, MD, FAHS, and Amaal J. Starling, MD, MS, FAHS |
Board Room |
| 9:00 am – 10:00 am | Media Training
Bert B. Vargas, MD, FAHS |
Board Room |
| 10:00 am – 12:00 pm | Speaker Training Session
Scott C. Litin, MD, FAHS |
Board Room |
| 12:00 pm – 12:15 pm | Morning Wrap-up
A. Laine Green, MD, MSc, FRCPC, FAHS |
Board Room |
| 12:15 pm – 1:15 pm | Lunch Break | Board Room |
| 1:15 pm – 2:15 pm | Context of Leadership
Steven M. Baskin, PhD |
Board Room |
| 2:15 pm – 3:15 pm | Psychology of Leadership
Mary Ann Berzins, MBA, FCIPD, SPHR-SCP |
Board Room |
| 3:15 pm – 3:30 pm | Break | |
| 3:30 pm – 4:00 pm | Social Media and Promotion
Lauren Doyle Strauss, DO, FAHS and Nada Hindiyeh, MD, FAHS |
Board Room |
| 4:00 pm – 4:30 pm | Topics in Advocacy
Amaal J. Starling, MD, MS, FAHS |
Board Room |
| 4:30 pm – 5:00 pm | Introduction to DEI Work
Cynthia E. Armand, MD and Clarimar Borrero-Mejias, MD |
Board Room |
| 5:15 pm – 6:15 pm | Advocate Panel Discussion
Olivia Begasse De Dhaem, MD, FAHS, Larry Charleston IV, MD, MS, FAHS, and Matthew S. Robbins, MD, FAHS |
Mesquite |
| 7:30 pm | Delegate Dinner | Rita’s Cantina |
Leadership in Advocacy Development (LEAD) Program
The 2023-2025 Leadership in Advocacy Development (LEAD) Program will take place in conjunction with the 2023 Scottsdale Headache Symposium®, November 15-19, 2023, and 2024 Headache on the Hill, March 18-19, 2024.
Participants will receive complimentary registration and expenses paid for the 2023 Scottsdale Headache Symposium and 2024 Headache on the Hill events.
Candidate Criteria
- Must be an AHS member in good standing for at least 3 years
- Must be 7+ years in clinical practice
- Must have a strong interest in practice management and/or advocacy
- Must commit to attending the 2023 Scottsdale Headache Symposium and 2024 Headache on the Hill events in person (expenses paid)
- Must commit to the development and completion of a proposed advocacy project over a 2-year longitudinal timeframe
Application and Supporting Materials
Applicants must complete the online application form and provide the following supporting materials:
- CV
- Letter of support speaking to the leadership potential and interest in advocacy of the applicant
- Personal statement up to 500 words. Questions to consider:
- What has motivated you to apply?
- What would you like to accomplish as an advocate?
- As a busy professional, how will you make time to pursue your advocacy project? How many hours per month can you dedicate?
- Health professional/physician advocacy project proposal up to 500 words describing your major goal/vision for the 2-year longitudinal program and your desired outcome. Questions to consider:
- What are you trying to do? What health problem are you trying to solve?
- How does this get done at present and what are the current challenges?
- What is novel about your approach? Why do you think you can be successful at this time?
2023 Application Timeline:
- Wednesday, July 19: Applications open
- Sunday, August 27: Applications due
- On or about Monday, September 18: Final decisions to be distributed
Leadership in Advocacy Development (LEAD) Program
The American Headache Society gratefully acknowledges the support of the 2023-2025 LEAD Program from our industry supporters:
 Lilly unites caring with discovery to create medicines that make life better for people around the world. We’ve been pioneering life-changing discoveries for nearly 150 years, and today our medicines help more than 47 million people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world’s most significant health challenges, redefining diabetes care, treating obesity and curtailing its most devastating long-term effects, advancing the fight against Alzheimer’s disease, providing solutions to some of the most debilitating immune system disorders, and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we’re motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit lilly.com and lilly.com/newsroom or follow us on Facebook, Instagram, and LinkedIn. |